UnitedHealth Group (NYSE:UNH) Price Target Raised to $466.00

UnitedHealth Group (NYSE:UNH) had its price target increased by research analysts at JPMorgan Chase & Co. from $420.00 to $466.00 in a research report issued on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the healthcare conglomerate’s stock. JPMorgan Chase & Co.‘s price objective points to a potential upside of 15.17% from the company’s current price.

UNH has been the topic of several other reports. Robert W. Baird boosted their price target on UnitedHealth Group from $278.00 to $287.00 and gave the stock an “underperform” rating in a research report on Wednesday, April 22nd. Erste Group Bank raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Monday, April 27th. Truist Financial upped their price objective on UnitedHealth Group from $395.00 to $440.00 and gave the company a “buy” rating in a report on Monday, June 1st. Jefferies Financial Group increased their price target on shares of UnitedHealth Group from $340.00 to $373.00 and gave the stock a “buy” rating in a research report on Monday, April 20th. Finally, Raymond James Financial raised UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 price objective for the company in a research report on Wednesday, April 1st. One investment analyst has rated the stock with a Strong Buy rating, twenty have assigned a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average target price of $406.33.

UnitedHealth Group Stock Up 1.3%

Shares of UnitedHealth Group stock traded up $5.15 on Monday, reaching $404.62. 2,110,347 shares of the company were exchanged, compared to its average volume of 8,935,257. UnitedHealth Group has a 1-year low of $234.60 and a 1-year high of $404.51. The company has a market cap of $367.45 billion, a P/E ratio of 30.55, a price-to-earnings-growth ratio of 1.61 and a beta of 0.64. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.80 and a quick ratio of 0.80. The stock’s 50 day moving average price is $348.12 and its 200-day moving average price is $323.61.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, beating analysts’ consensus estimates of $6.76 by $0.47. The company had revenue of $111.65 billion during the quarter, compared to analysts’ expectations of $109.84 billion. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The firm’s revenue for the quarter was up 2.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $7.20 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, equities analysts forecast that UnitedHealth Group will post 18.32 EPS for the current year.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of the business’s stock in a transaction that occurred on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the sale, the chief executive officer owned 17,805 shares in the company, valued at approximately $6,320,775. The trade was a 4.30% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 0.28% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Sarver Vrooman Wealth Advisors acquired a new position in shares of UnitedHealth Group during the 4th quarter worth $25,000. Beacon Financial Strategies CORP acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $26,000. Anfield Capital Management LLC grew its stake in UnitedHealth Group by 220.0% in the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock valued at $26,000 after acquiring an additional 55 shares during the period. Joseph Group Capital Management bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $27,000. Finally, Nalls Sherbakoff Group LLC bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $27,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.